Equillium, Inc. - Common Stock — Cash Flow (NASDAQ:EQ) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities -24.62 M-32.08 M-8.73 M-21.78 M-19.03 M-22.75 M -18.88 M Cash from investing activities -18.59 M27.41 M18.68 M-4.76 M13.81 M4.46 M -35 K Cash from financing activities 53.95 M31.06 M-1.22 M-9.23 M164 K30.43 M 65.68 M Free cash flow -24.62 M-32.08 M-8.73 M-21.78 M-19.03 M-22.79 M -18.93 M

News

Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)

Equillium (EQ) SVP Zedelmayer sells $300k in shares

Equillium secures $35M financing from RA Capital Management

Roth/MKM initiates Equillium stock with buy on ulcerative colitis drug

Equillium SVP Zedelmayer sells $328k in shares

Stifel initiates Equillium stock with buy rating on IBD potential

Equillium principal accounting officer Tom Penny sells $8427 in stock

Equillium SVP Zedelmayer sells $7.7k in stock

The Zacks Analyst Blog Highlights MS, VOO, SPY, IVV, SPYM, RSP, EQ and EQWL

Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases - Slideshow (NASDAQ:EQ) 2025-11-09

Equillium announces leadership changes as it shifts focus to EQ504

Equillium files prospectus supplement for up to $75 million stock offering